A detailed history of Twin Lakes Capital Management, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Twin Lakes Capital Management, LLC holds 19,955 shares of PFE stock, worth $533,197. This represents 0.39% of its overall portfolio holdings.

Number of Shares
19,955
Previous 19,809 0.74%
Holding current value
$533,197
Previous $549,000 1.64%
% of portfolio
0.39%
Previous 0.38%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$25.26 - $29.6 $3,687 - $4,321
146 Added 0.74%
19,955 $558,000
Q1 2024

May 10, 2024

BUY
$25.89 - $29.73 $3,935 - $4,518
152 Added 0.77%
19,809 $549,000
Q4 2023

Feb 08, 2024

BUY
$26.13 - $33.94 $3,396 - $4,412
130 Added 0.67%
19,657 $565,000
Q2 2023

Aug 08, 2023

BUY
$36.12 - $41.79 $3,467 - $4,011
96 Added 0.49%
19,527 $716,000
Q1 2023

May 09, 2023

BUY
$39.39 - $51.28 $3,584 - $4,666
91 Added 0.47%
19,431 $792,000
Q4 2022

Feb 03, 2023

SELL
$41.75 - $54.5 $459 - $599
-11 Reduced 0.06%
19,340 $991,000
Q3 2022

Oct 21, 2022

BUY
$43.76 - $53.42 $3,457 - $4,220
79 Added 0.41%
19,351 $847,000
Q2 2022

Aug 15, 2022

SELL
$46.53 - $55.17 $4,327 - $5,130
-93 Reduced 0.48%
19,272 $1.01 Million
Q1 2022

May 12, 2022

BUY
$45.75 - $56.69 $3,431 - $4,251
75 Added 0.39%
19,365 $1 Million
Q4 2021

Feb 07, 2022

BUY
$41.32 - $61.25 $3,222 - $4,777
78 Added 0.41%
19,290 $1.14 Million
Q3 2021

Nov 01, 2021

BUY
$39.25 - $50.42 $3,925 - $5,042
100 Added 0.52%
19,212 $826,000
Q2 2021

Aug 06, 2021

BUY
$35.91 - $40.68 $1,903 - $2,156
53 Added 0.28%
19,112 $748,000
Q1 2021

May 18, 2021

BUY
$33.49 - $37.77 $24,615 - $27,760
735 Added 4.01%
19,059 $691,000
Q4 2020

Feb 26, 2021

BUY
$33.47 - $42.56 $613,304 - $779,869
18,324 New
18,324 $675,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Twin Lakes Capital Management, LLC Portfolio

Follow Twin Lakes Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twin Lakes Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Twin Lakes Capital Management, LLC with notifications on news.